IRS 990 Nonprofit Profile
Rare Bird Foundation
Working with our partners worldwide , rare bird aims to create the first-ever globally approved drug to tackle the transcription factor myocyte enhancer factor 2c mef2c deficiency within five years.
- Filing year
- 2024
- Total revenue
- $202K
- Total expenses
- $3K
- Program expenses
- $0
- Administration
- $3K
- Fundraising
- $0
- Program share of expenses
- 0%
- EIN
- 993963516
- Location
- Glenview, IL
About CharitySense
CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.
See live projects or read our insights on nonprofit accountability.
Financial data on this page is sourced from IRS Form 990 filings.